This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Celanese (CE) Hits a 52-Week High: What's Driving the Stock?
by Zacks Equity Research
An upbeat outlook coupled with strategic acquisitions and internal growth initiatives are contributing to a rally in Celanese's (CE) shares.
Celanese (CE) Announces Price Increase of MIBK and MIBC
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment which should lend support to margins.
Celanese to Hike Price of Acetate-Based Emulsions in China
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment which should lend support to margins.
Celanese's Polyacetal Facility Comes Online in Saudi Arabia
by Zacks Equity Research
Celanese (CE) declares its polyacetal facility of Ibn Sina Joint Venture commercially operational. This will serve the company's economic interest by providing further financial benefits.
Celanese (CE) Set to Increase Acetyl Intermediates Prices
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment which should lend support to margins.
Celanese (CE) Signs Agreement to Acquire Omni Plastics
by Zacks Equity Research
Celanese's (CE) latest move strengthens its global asset base by adding compounding capacity in the Americas to continue to support a diverse and growing customer base.
The Zacks Analyst Blog Highlights: Kronos Worldwide, Westlake Chemical, Kraton, Albemarle and Celanese
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Kronos Worldwide, Westlake Chemical, Kraton, Albemarle and Celanese
Celanese (CE) Set to Increase Acetyl Intermediates Prices
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment which should lend support to margins.
U.S. Chemical Industry Set to Ride High: 5 Stocks for 2018
by Zacks Equity Research
As the U.S. chemical industry's upturn is expected to continue in 2018, it would be a prudent idea to invest in chemical stocks with compelling growth prospects.
Celanese (CE) Inaugurates Customer Solution Center in Tokyo
by Zacks Equity Research
Celanese's (CE) Customer Solution Center in Tokyo has been geared to support the growth of its customers in Asia.
Celanese (CE) Set to Increase Acetyl Intermediate Prices
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to margins.
Zacks.com featured highlights: Monsanto, International Consolidated Airlines, Microchip Technology, CBRE and Celanese
by Zacks Equity Research
Zacks.com featured highlights: Monsanto, International Consolidated Airlines, Microchip Technology, CBRE and Celanese
Chemical Industry Recovers from Hurricanes, October Output Up
by Zacks Equity Research
Global chemical production rose 0.4% in October on gains across all chemical producing regions.
Markets Volatile on Senate Tax Bill: 5 Top ROE Picks
by Supriyo Bose
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
Celanese's (CE) Subsidiary Prices Senior Notes Offering
by Zacks Equity Research
Celanese's (CE) subsidiary prices ???300M principal amount of 1.25% Senior Notes due 2025. The company plans to use the net proceeds from the offering to fund its qualified U.S. pension plans and general corporate purposes.
Celanese (CE) Set to Raise Acetaldehyde Price in Europe
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to margins.
Celanese (CE) Shares Up 36% YTD: What's Driving the Stock?
by Zacks Equity Research
Forecast-topping earnings performance and upbeat outlook have contributed to a rally in Celanese's (CE) shares.
6 Reasons That Make Celanese (CE) an Attractive Pick
by Zacks Equity Research
Based on its upbeat prospects, we believe Celanese (CE) is a viable investment option.
Celanese (CE) Well Poised on Productivity and Growth Actions
by Zacks Equity Research
Celanese's (CE) productivity actions and growth initiatives, including acquisitions, are likely to lend support to its earnings in 2017.
Celanese (CE) to Hike Acetyl Intermediates Price in Asia
by Zacks Equity Research
Celanese (CE) is taking appropriate pricing actions amid a volatile raw material pricing environment, which should lend support to its margins.
Markets Rebound as Senate Passes Tax Bill: 5 Top ROE Picks
by Supriyo Bose
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.
Celanese (CE) Down 3.7% Since Earnings Report: Can It Continue?
by Zacks Equity Research
Celanese (CE) reported earnings a month ago. What's next for the stock? We take a look at earnings estimates for some clues.
Chemicals Industry Stock Outlook - November 2017
by Anindya Barman
The highly cyclical industry has enjoyed a positive run this year, helped by an upswing in the world economy and continued strength across major end-use markets.
Zacks.com featured highlights Monsanto, CBRE Group, Pepsico, Applied Materials and Celanese
by Zacks Equity Research
Zacks.com featured highlights Monsanto, CBRE Group, Pepsico, Applied Materials and Celanese
5 Top ROE Stocks to Buy as Q3 Earnings Near All-Time High
by Supriyo Bose
ROE helps investors distinguish profit-generating companies from profit burners and is useful in determining the financial health of a company.